Cellular Post-Conditioning: Allogeneic Cardiosphere-Derived Cells Reduce Infarct Size and Attenuate Microvascular Obstruction When Administered After Reperfusion in Pigs With Acute Myocardial Infarction
暂无分享,去创建一个
E. Marbán | K. Fukuda | R. Gallet | R. Middleton | James F Dawkins | E. Tseliou | H. Kanazawa | M. Kreke | K. Malliaras | D. Luthringer | R. Makkar | G. Couto | Kristine Yee | Jeffrey Seinfeld | L. Marban | Ke Cheng | Ileana Valle | R. Rachel | Smith | Supurna | Chowdhury | J. Dawkins | L. Marbán
[1] E. Marbán,et al. Validation of Contrast-Enhanced Magnetic Resonance Imaging to Monitor Regenerative Efficacy After Cell Therapy in a Porcine Model of Convalescent Myocardial Infarction , 2013, Circulation.
[2] R. Kloner. Current State of Clinical Translation of Cardioprotective Agents for Acute Myocardial Infarction , 2013, Circulation research.
[3] P. Serruys,et al. Intracoronary Infusion of Allogeneic Mesenchymal Precursor Cells Directly After Experimental Acute Myocardial Infarction Reduces Infarct Size, Abrogates Adverse Remodeling, and Improves Cardiac Function , 2013, Circulation research.
[4] E. Marbán,et al. Allogeneic cardiospheres safely boost cardiac function and attenuate adverse remodeling after myocardial infarction in immunologically mismatched rat strains. , 2013, Journal of the American College of Cardiology.
[5] E. Marbán,et al. Cardiomyocyte proliferation and progenitor cell recruitment underlie therapeutic regeneration after myocardial infarction in the adult mouse heart , 2013, EMBO molecular medicine.
[6] Eduardo Marbán,et al. Magnetic Enhancement of Cell Retention, Engraftment, and Functional Benefit after Intracoronary Delivery of Cardiac-Derived Stem Cells in a Rat Model of Ischemia/Reperfusion , 2012, Cell transplantation.
[7] Daniel Berman,et al. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial , 2012, The Lancet.
[8] E. Marbán,et al. Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells. , 2012, Journal of the American College of Cardiology.
[9] E. Marbán,et al. Safety and Efficacy of Allogeneic Cell Therapy in Infarcted Rats Transplanted With Mismatched Cardiosphere-Derived Cells , 2012, Circulation.
[10] Marcus F Stoddard,et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial , 2011, The Lancet.
[11] S. Combes,et al. Delayed Postconditioning in the Mouse Heart In Vivo , 2011, Circulation.
[12] L. V. Van Laake,et al. miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes , 2011, The Journal of experimental medicine.
[13] F. Carlotti,et al. Mesenchymal stem cells or cardiac progenitors for cardiac repair? A comparative study , 2011, Cellular and Molecular Life Sciences.
[14] Alessandro Giacomello,et al. Relative Roles of Direct Regeneration Versus Paracrine Effects of Human Cardiosphere-Derived Cells Transplanted Into Infarcted Mice , 2010, Circulation research.
[15] Hiroshi Sato,et al. Intracoronary Administration of Cardiac Progenitor Cells Alleviates Left Ventricular Dysfunction in Rats With a 30-Day-Old Infarction , 2010, Circulation.
[16] Tetsuo Sasano,et al. Engraftment, Differentiation, and Functional Benefits of Autologous Cardiosphere-Derived Cells in Porcine Ischemic Cardiomyopathy , 2009, Circulation.
[17] Leelee Ong,et al. Is the intravascular administration of mesenchymal stem cells safe? Mesenchymal stem cells and intravital microscopy. , 2009, Microvascular research.
[18] H. Matsubara,et al. Controlled delivery of basic fibroblast growth factor promotes human cardiosphere-derived cell engraftment to enhance cardiac repair for chronic myocardial infarction. , 2008, Journal of the American College of Cardiology.
[19] A. Ganser,et al. Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction. , 2008, European heart journal.
[20] M. Gnecchi,et al. Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy , 2008, Circulation research.
[21] E. Andreu,et al. Characterization of the paracrine effects of human skeletal myoblasts transplanted in infarcted myocardium , 2008, European journal of heart failure.
[22] R. Jaffe,et al. Microvascular Obstruction and the No-Reflow Phenomenon After Percutaneous Coronary Intervention , 2008, Circulation.
[23] Lawrence Buja,et al. Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction. , 2008, Journal of molecular and cellular cardiology.
[24] Y. Yoon,et al. Role of host tissues for sustained humoral effects after endothelial progenitor cell transplantation into the ischemic heart , 2007, The Journal of experimental medicine.
[25] M. Swindle,et al. Swine in the laboratory: surgery, anesthesia, imaging, and experimental techniques , 2007 .
[26] A. Zeiher,et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. , 2006, The New England journal of medicine.
[27] Robert L Wilensky,et al. A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. , 2006, European heart journal.
[28] J. Ingwall,et al. Evidence supporting paracrine hypothesis for Akt‐modified mesenchymal stem cell‐mediated cardiac protection and functional improvement , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[29] Jong Chun Park,et al. The effects of mesenchymal stem cells transduced with Akt in a porcine myocardial infarction model. , 2005, Cardiovascular research.
[30] J. Downey,et al. Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways. , 2004, Journal of the American College of Cardiology.
[31] R. Guyton,et al. Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion. , 2004, Cardiovascular research.
[32] M. Greeley,et al. Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs , 2004, The Lancet.
[33] R. Guyton,et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. , 2003, American journal of physiology. Heart and circulatory physiology.
[34] J. Boura,et al. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction : a quantitative review of 23 randomised trials , 2022 .
[35] K. Okumura,et al. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. , 2000, Journal of the American College of Cardiology.
[36] J. Vinten-johansen,et al. The role of neutrophils in myocardial ischemia-reperfusion injury. , 1999, Cardiovascular research.
[37] B. Brodie,et al. Importance of time to reperfusion for 30-day and late survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarction. , 1998, Journal of the American College of Cardiology.
[38] Katherine C. Wu,et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. , 1998, Circulation.
[39] M. Hori,et al. Clinical implications of the 'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. , 1996, Circulation.
[40] G. Lamas,et al. Ventricular remodeling after myocardial infarction. , 1993, Advances in experimental medicine and biology.
[41] M. Pfeffer,et al. Ventricular Remodeling After Myocardial Infarction: Experimental Observations and Clinical Implications , 1990, Circulation.
[42] M. Fishbein,et al. Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. , 1981, American heart journal.